Gonorrhea May Become Resistant to All Antibiotics Sooner Than Anticipated

A cluster of cases in Hawaii show signs of resistance to the two drugs used to treat it

Neisseria Gonorrhoeae.

Join Our Community of Science Lovers!

Experts have been worried for a while that time is running out for the last working cures for gonorrhea infections. On Wednesday, some revealed there may be even less time left on the clock than had been previously thought.

Scientists from the Centers for Disease Control and Prevention and Hawaii’s department of health reported a cluster of cases of gonorrhea in that state in which the Neisseria gonorrhoeae bacteria showed high-level resistance to one of the drugs, azithromycin, as well as reduced susceptibility to the second drug, ceftriaxone.

The two drugs are used in combination, a move experts hope will slow down the bacteria’s relentless march through the antibiotic medicine cabinet.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


There had already been signs that the bacteria, which have vanquished multiple other antibiotics, were starting to be able to evade these ones as well. Since 2005, there have been four isolated cases reported in which the Neisseria gonorrhoeae bacteria had reduced susceptibility to both drugs. But this is the first time a cluster of such cases has been seen in the US.

“Our last line of defense against gonorrhea is weakening,” Dr. Jonathan Mermin, director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention said in a statement.

“If resistance continues to increase and spread, current treatment will ultimately fail and 800,000 Americans a year will be at risk for untreatable gonorrhea.”

Untreated gonorrhea can cause chronic pelvic pain, infertility, and ectopic pregnancies—in which a fertilized egg starts to develop in a fallopian tube, not the uterus. Ectopic pregnancies can be life-threatening.

The cluster of cases described by Dr. Alan Katz of Hawaii’s state board of health involved six men and a woman, but was in fact undoubtedly larger. They did not have sex with each other, so must have been infected by other people.
Katz said the seven people reported a total of eight sexual partners. Four of the eight agreed to be tested, but none was infected.

Analysis of the genetic sequences of the viruses showed they were closely related, Katz said.

All seven people were cured of their infections. But it seems only a matter of time before treatment failures occur. Earlier this year doctors from Britain reported that a man infected with gonorrhea was not cured by his first course of antibiotics, though follow-up treatment three months later did quell the infection.

If this combination of drugs fail, there is no other treatment option currently available. Several experimental antibiotics are in development and one has recently been shown to be effective in a Phase 2 trial. But it is still likely years away from hitting the market.

Republished with permission from STAT. This article originally appeared on September 21, 2016

Helen Branswell is STAT's infectious diseases and public health reporter. She comes from the Canadian Press, where she was the medical reporter for the past 15 years. Helen cut her infectious diseases teeth during Toronto's SARS outbreak in 2003 and spent the summer of 2004 embedded at the US Centers for Disease Control and Prevention. In 2010-11 she was a Nieman Global Health Fellow at Harvard, where she focused on polio eradication. Warning: Helen asks lots of questions.

More by Helen Branswell

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe